Andhra Sugars’ aspirin facility gets USFDA nod

BL Hyderabad Bureau Updated - November 07, 2024 at 07:43 PM.

The inspection, which took place in September, determined that the facility is in compliance with all applicable USFDA standards

Andhra Sugars Ltd has announced that its aspirin manufacturing facility in Venkatarayapuram in Andhra Pradesh has passed a US Food and Drug Administration (FDA) inspection. The inspection, which took place in September, determined that the facility is in compliance with all applicable USFDA standards.

This means that the facility meets the stringent global quality standards necessary to ensure the availability of medicines that meet the most stringent norms.

Andhra Sugars Ltd was established in 1947 to use locally available renewable resources to produce value-added products. The company has since expanded and diversified over the years and now produces sugar, power, organic and inorganic chemicals, fertilisers, aspirin, and salicylic acid at its six integrated complexes at Tanuku, Kovvur, Guntur, Taduvai, Saggonda and Bhimadole.

Published on November 7, 2024 13:37

This is a Premium article available exclusively to our subscribers.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

You have reached your free article limit.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

You have reached your free article limit.
Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

TheHindu Businessline operates by its editorial values to provide you quality journalism.

This is your last free article.